Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID)
- PMID: 1680289
- PMCID: PMC1683191
Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID)
Abstract
We have identified a previously unrecognized missense mutation in a patient with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). The mutation is a G646-to-A transition at a CG dinucleotide and predicts a glycine-to-arginine substitution at codon 216. Computer analysis of secondary structure predicts a major alteration with loss of a beta-pleated sheet in a highly conserved region of the protein. The basepair substitution also generates a new site for the restriction enzyme BstXI in exon 7 of the genomic DNA. Digestion of genomic DNA from the patient and from his parents revealed that he was homozygous for the mutation and that his mother and father were carriers. This mutation in homozygous form appears to be associated with very severe disease, since the patient had perinatal onset of clinical manifestations of SCID, the highest concentration of the toxic metabolite deoxyATP in nine patients studied, and a relatively poor immunologic response during the initial 2 years of therapy with polyethylene glycol-adenosine deaminase. Analysis of DNA from 21 additional patients with ADA-SCID and from 19 unrelated normals revealed that, while none of the normal individuals showed the abnormal restriction fragment, two of the 21 patients studied were heterozygous for the G646-to-A mutation.
Similar articles
-
Homozygosity for a missense mutation (G20R) associated with neonatal onset adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID).Clin Immunol Immunopathol. 1994 Feb;70(2):171-5. doi: 10.1006/clin.1994.1026. Clin Immunol Immunopathol. 1994. PMID: 8299233
-
Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).Cell Immunol. 1993 Dec;152(2):383-93. doi: 10.1006/cimm.1993.1299. Cell Immunol. 1993. PMID: 8258146
-
Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes.Hum Genet. 1997 Jul;100(1):22-9. doi: 10.1007/s004390050460. Hum Genet. 1997. PMID: 9225964
-
Adenosine deaminase deficiency.Immunodefic Rev. 1990;2(3):175-98. Immunodefic Rev. 1990. PMID: 2078332 Review.
-
Genotype is an important determinant of phenotype in adenosine deaminase deficiency.Curr Opin Immunol. 2003 Oct;15(5):571-7. doi: 10.1016/s0952-7915(03)00104-3. Curr Opin Immunol. 2003. PMID: 14499267 Review.
Cited by
-
Severe Combined Immunodeficiency (SCID)-the Irish Experience.J Clin Immunol. 2021 Nov;41(8):1950-1953. doi: 10.1007/s10875-021-01106-3. Epub 2021 Aug 10. J Clin Immunol. 2021. PMID: 34374883 No abstract available.
-
Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1).Blood. 2008 Jan 1;111(1):209-18. doi: 10.1182/blood-2007-04-082552. Epub 2007 Sep 17. Blood. 2008. PMID: 17875809 Free PMC article.
-
Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.Am J Hum Genet. 1998 Oct;63(4):1049-59. doi: 10.1086/302054. Am J Hum Genet. 1998. PMID: 9758612 Free PMC article.
-
Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.J Clin Invest. 1993 Nov;92(5):2291-302. doi: 10.1172/JCI116833. J Clin Invest. 1993. PMID: 8227344 Free PMC article.
-
Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.Am J Hum Genet. 1994 Jul;55(1):59-68. Am J Hum Genet. 1994. PMID: 8023852 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials